Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
Part of paid clinical trials in Carmel, Indiana.
- Sponsor
- Claris Biotherapeutics, Inc.
- Study ID
- NCT07636590
- Status
- Recruiting
Conditions
- Limbal Stem Cell Deficiency
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Non-interventional — OTHERNon-interventional
Study Details
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
Key Dates
- Start date
- May 22, 2026
- Status verified
- May 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: Non-interventionalNo product administration.
Primary Outcome Measure
Natural Progression of LSCD as Assessed by Changes in Patient Reported Outcomes [ Time Frame: Screening through Week 84 ]
Central Contacts
- Central Operations Representative919-205-0012
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Midwest Cornea Associates, LLC | Carmel | Indiana | 46290 | Study Coordinator |
| Francis Price Jr, MD | Indianapolis | Indiana | 46260 | Study Coordinator |
Find similar trials in Carmel, IN
Related Studies
- Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell DeficiencyPHASE1 · Recruiting · Claris Biotherapeutics, Inc. · Loma Linda, California